These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2305013)

  • 1. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.
    Flicker C; Serby M; Ferris SH
    Psychopharmacology (Berl); 1990; 100(2):243-50. PubMed ID: 2305013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity to scopolamine in the elderly.
    Flicker C; Ferris SH; Serby M
    Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of scopolamine on working memory in healthy young volunteers.
    Rusted JM; Warburton DM
    Psychopharmacology (Berl); 1988; 96(2):145-52. PubMed ID: 3148139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of scopolamine on matching to sample paradigm and related tests in human subjects.
    Koller G; Satzger W; Adam M; Wagner M; Kathmann N; Soyka M; Engel R
    Neuropsychobiology; 2003; 48(2):87-94. PubMed ID: 14504417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia.
    Robbins TW; Semple J; Kumar R; Truman MI; Shorter J; Ferraro A; Fox B; McKay G; Matthews K
    Psychopharmacology (Berl); 1997 Nov; 134(1):95-106. PubMed ID: 9399372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of scopolamine and diazepam on working memory.
    Rusted JM; Eaton-Williams P; Warburton DM
    Psychopharmacology (Berl); 1991; 105(3):442-5. PubMed ID: 1798839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.
    Parrott AC
    Psychopharmacology (Berl); 1986; 89(3):347-54. PubMed ID: 3088662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociative effects of scopolamine on working memory in healthy young volunteers.
    Rusted JM
    Psychopharmacology (Berl); 1988; 96(4):487-92. PubMed ID: 3149771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine attenuates scopolamine-induced memory impairment in humans.
    Riedel W; Hogervorst E; Leboux R; Verhey F; van Praag H; Jolles J
    Psychopharmacology (Berl); 1995 Nov; 122(2):158-68. PubMed ID: 8848531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic challenge and cognitive functions: a comparison between young and elderly normal subjects.
    Zemishlany Z; Thorne AE
    Isr J Psychiatry Relat Sci; 1991; 28(3):32-41. PubMed ID: 1800456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.
    Broocks A; Little JT; Martin A; Minichiello MD; Dubbert B; Mack C; Tune L; Murphy DL; Sunderland T
    Biol Psychiatry; 1998 Mar; 43(6):408-16. PubMed ID: 9532345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Dennes RP; Barnes JC
    Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.
    Hodges DB; Lindner MD; Hogan JB; Jones KM; Markus EJ
    Behav Pharmacol; 2009 May; 20(3):237-51. PubMed ID: 19436198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine does not disrupt spatial working memory in rats.
    Godding PR; Rush JR; Beatty WW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):919-23. PubMed ID: 7111351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.
    Mewaldt SP; Ghoneim MM
    Pharmacol Biochem Behav; 1979 Feb; 10(2):205-10. PubMed ID: 450929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cholinergic systems in visuospatial processing and memory.
    Meador KJ; Moore EE; Nichols ME; Abney OL; Taylor HS; Zamrini EY; Loring DW
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):832-42. PubMed ID: 8276939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory.
    Sloan EP; Fenton GW; Standage KP
    Biol Psychiatry; 1992 Mar; 31(6):600-6. PubMed ID: 1581439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model.
    Molchan SE; Martinez RA; Hill JL; Weingartner HJ; Thompson K; Vitiello B; Sunderland T
    Brain Res Brain Res Rev; 1992; 17(3):215-26. PubMed ID: 1467811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.